| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $638.1M | +19.9% |
| Gross Profit | $112.9M | — |
| R&D Expense | $112.4M | +22.1% |
| SG&A Expense | $118.1M | +18.0% |
| Operating Income | -$154.1M | -5.5% |
| Pre-tax Income | -$175.8M | -6.7% |
| Income Tax | -$387K | -145.9% |
| Net Income | -$175.4M | -5.9% |
| EPS (Basic) | -$1.55 |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $91.2M | -19.0% |
| Short-term Investments | $44.8M | +11.2% |
| Accounts Receivable | $57.4M | +12.2% |
| Current Assets | $275.6M | -0.3% |
| Total Assets | $910.3M | +34.2% |
| Current Liabilities | $191.5M | +57.8% |
| Long-term Debt | $447.5M | +45.1% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $34.7M | +346.6% |
| Capital Expenditures | $4.1M | -35.7% |
| Investing Cash Flow | -$160.0M | -340.5% |
| Financing Cash Flow | $105.4M | +699.2% |
| Free Cash Flow | $30.5M | +249.0% |
| +1.3% |
| EPS (Diluted) | -$1.55 | +1.3% |
| Total Liabilities |
| $727.9M |
| +40.5% |
| Stockholders' Equity | $182.4M | +13.6% |